TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04325334

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Running volume increase
Description: Participants will receive a 12-week running program to increase their running volume by approximately 10% per week on average, and in accordance with the 10% rule advocated to minimize injury rates. For the purpose of this study, participants will run using their habitual technique - i.e. no specific instructions on 'how' to run will be provided; rather, they will simply be instructed on 'how much' to run.
Study: NCT00431626

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dutasteride (Avodart)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo before and after treatment of TURP
Study: NCT01347528

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Medication Adherence Support System (MASS)
Description: The intervention consists of the use of an electronic Medication Adherence Monitor for a 6-month period as well as 2 visits to the heart failure outpatient clinic of the TweeSteden hospital (usual care). This monitor (a) dispenses all prescribed medication in the right dosage at the specified time, (b) reminds patients to take their medications through an alarm, sms or voicemail service and records adherence, and (c) sends critical data about non-adherence to the heart failure nurse, via a web application (CarebyWeb). The Medication Adherence Monitor is provided to the patient by the hospital pharmacy, including an instruction how to use the device. After the intervention patients return to usual care only. We expect a training effect, with continued improved adherence in the intervention group.
Study: NCT01936714

Intervention type: PROCEDURE
Group type: OTHER
Intervention: cataract surgery

Intervention type: PROCEDURE
Group type: OTHER
Intervention: cataract surgery
Study: NCT02346045

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Renal sympathetic denervation
Description: In the experimental arm, Intervention is renal sympathetic denervation using Symplicity® system (Medtronic Ardian Inc, Mountain View, CA, USA) and antihypertensive medications previously prescribed~1. After femoral puncture guiding catheter is engaged in renal artery~2. Symplicity radiofrequency ablation catheter is inserted into renal artery and by circular sequence, from distal to proximal portion, ablation energy is applied to the wall of renal artery~3. 4-5 ablations are applied in each renal artery.~In the sham comparator, intervention is renal angiogram and continue antihypertensive medications previuosly decribed
Study: NCT00895154

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Tutoring
Description: Participants will be tutored for approximately 8-10 hours per month during the school year.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: General Tutoring
Description: Participants will be tutored for approximately 8-10 hours per month during the school year.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Memory Training
Description: Participants will receive memory training for approximately 8-10 hours per month during the school year.
Study: NCT01993927

Intervention type: DRUG
Intervention: Voglibose
Description: Voglibose Tablets / Voglibose OD Tablets
Study: NCT03702231

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Recombinant, Adjuvanted
Description: A series of 2 doses of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) will be given on a 0- and 3-month schedule by intramuscular injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Recombinant, Adjuvanted
Description: A series of 2 doses of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) will be given on a 0- and 3-month schedule by intramuscular injection.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Zoster Vaccine Recombinant, Adjuvanted
Description: A series of 2 doses of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) will be given on a 0- and 3-month schedule by intramuscular injection.
Study: NCT03095677

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Program of training with exercises including apnea
Description: 16 training session on cycle ergometry with exercises including apneas.

Intervention type: OTHER
Group type: OTHER
Intervention: Program of training with exercises without apnea
Description: 16 training session on cycle ergometry with exercises without apnea
Study: NCT01353768

Intervention type: OTHER
Intervention: retrospective chart review
Description: retrospective chart review
Study: NCT04018573

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PATHS Sexual Communication Toolkit
Description: The PATHS Sexual Communication Toolkit is a self-guided, online intervention. The toolkit is comprised of 6 modules, covering a range of topics relevant to increasing parents' motivation, self-efficacy, and intention for communicating about sex. Material is presented in a variety of modalities (e.g., text, videos of experts, videos of other parents describing their experiences). Parents set personalized goals for themselves regarding activities and conversations they want to have with their sons, selecting from a menu of options provided by the intervention. A 1-month booster module queries parents about whether they have achieved their goals, and provides customized content to support the behaviors parents have yet to enact.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Parent Support Film
Description: Lead with Love is a 35-minute education entertainment film created to provide support, information, and behavioral guidance to parents of lesbian, gay, or bisexual (LGB) children. Drawing from stage-based models of behavior change, and social cognitive theory, it aims to help parents progress through the process of coming to accept their child's sexual orientation, recognizing the importance of their behaviors and reactions to their child's health, and accepting their child's sexual orientation, and engaging in behaviors that are more supportive and less rejecting. This is achieved by telling the true stories of four families and how they responded to the news that their child was LGB, and by having experts (psychologists, teachers, clergy) provide information and guidance.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Support Film
Description: Lead with Love is a 35-minute education entertainment film created to provide support, information, and behavioral guidance to parents of lesbian, gay, or bisexual (LGB) children. Drawing from stage-based models of behavior change, and social cognitive theory, it aims to help parents progress through the process of coming to accept their child's sexual orientation, recognizing the importance of their behaviors and reactions to their child's health, and accepting their child's sexual orientation, and engaging in behaviors that are more supportive and less rejecting. This is achieved by telling the true stories of four families and how they responded to the news that their child was LGB, and by having experts (psychologists, teachers, clergy) provide information and guidance.
Study: NCT03300973

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sling surgery
Description: transoburator vaginal tape ,inside out procedure under spinal anathesia

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sling surgery
Description: transoburator vaginal tape ,inside out procedure under spinal anathesia
Study: NCT04218045

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic single anastomosis sleeve ileal bypass
Description: a simple loop gastro-ileal bypass is added to the sleeve procedure.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy
Description: Conventional sleeve gastrectomy using endoscopic stapler
Study: NCT04288609

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intendu
Description: Cognitive remediation using VR adaptive platform for response inhibition, self-initiation, cognitive flexibility, sustained attention, divided attention, working memory, planning, persistence.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Paper and Pencil cognitive remediation training
Description: Cognitive remediation using paper and pencil tasks for response inhibition, self-initiation, cognitive flexibility, sustained attention, divided attention, working memory, planning, persistence.
Study: NCT02883998

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Outpatient Physical Therapy
Description: traditional outpatient physical therapy which occurs at a physical therapy office

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Home Base Physical Therapy
Description: Patients will be provided a packet of exercises via a website which allows access to instructional physical therapy videos specifically designated for UKA patients and equipment to perform the home based physical therapy
Study: NCT03090828

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: app-based therapeutic education
Description: Patients will connect to a platform providing information on end-stage renal disease and to contact health care providers.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: enhanced app-based therapeutic education
Description: Patients in the enhanced app group will also have access to a social network. (forum, chat room)
Study: NCT03392285

Intervention type: DEVICE
Intervention: Internal fixation or hip arthroplasty
Description: Patients treated according to the routine at the orthopedic department with screw fixation of an undisplayed femoral neck fracture or hip arthroplasty for a displaced femoral neck fracture.

Intervention type: DEVICE
Intervention: Internal fixation or hip arthroplasty
Description: Patients treated according to the routine at the orthopedic department with screw fixation of an undisplayed femoral neck fracture or hip arthroplasty for a displaced femoral neck fracture.
Study: NCT01174290

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Haloperidol decanoate
Description: IV q6h.~Study drug will be continued until one of the following study withdrawal/termination criteria is met:~1. Delirium (ICDSC ≥ 4) develops. The diagnosis of delirium will be confirmed in all instances by the Psychiatric Consultation Service, Division of Psychiatry, Tufts Medical Center using DSM-IV criteria.~2. The patient is discharged from the ICU at Tufts MC.~3. 10 days of study drug administration occurs.~4. The subject experiences an adverse event potentially attributable to the study drug that is deemed, in the opinion of one of the physicians on the study team or the MICU team, to warrant discontinuation of therapy.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: D5W 0.2mL IV q6h~Study drug will be continued until one of the following study withdrawal/termination criteria is met:~1. Delirium (ICDSC ≥ 4) develops. The diagnosis of delirium will be confirmed in all instances by the Psychiatric Consultation Service, Division of Psychiatry, Tufts Medical Center using DSM-IV criteria.~2. The patient is discharged from the ICU at Tufts MC.~3. 10 days of study drug administration occurs.~4. The subject experiences an adverse event potentially attributable to the study drug that is deemed, in the opinion of one of the physicians on the study team or the MICU team, to warrant discontinuation of therapy.
Study: NCT03026985

Intervention type: OTHER
Intervention: Observational cohort
Description: Ultrasound assessment of quadriceps, muscle strength testing, highest mobility level
Study: NCT04065945

Intervention type: OTHER
Intervention: Completion questionnaires/providing biological samples
Description: Participant completes baseline interview at enrollment, then completes questionnaires and provides biological samples at each scheduled study visit.

Intervention type: OTHER
Intervention: Completion questionnaires/providing biological samples
Description: Participant completes baseline interview at enrollment, then completes questionnaires and provides biological samples at each scheduled study visit.
Study: NCT04261426

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Immunoglobulin
Description: IVIG 0.5g/kg/d for 5 days

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard care
Description: Standard care

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard care
Description: Standard care
Study: NCT00156637

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Team-Based Quality Improvement Intervention
Description: Intervention to improve recommended dosing and side effect monitoring of antipsychotic medications using a team-based quality improvement effort
Study: NCT03540056

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: We use ultrasound to measure the PRF and the testicular volumes.

Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasound
Description: We use ultrasound to measure the PRF and the testicular volumes.
Study: NCT01004211

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Narrow band imaging transurethral resection
Description: Transurethral resection of bladder lesion by mean of narrow band imaging

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard transurethral resection
Description: Transurethral resection of bladder lesion by mean of standard white light
Study: NCT00156637

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Opinion Leader Intervention
Description: Intervention to improve recommended dosing and side effect monitoring of antpsychotic medications using an Opion leader quality improvement effort

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Team Based Quality Improvement
Description: Intervention to increase appropriate use of clozapine through a team based quality intervention.
Study: NCT00112047

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Emtricitabine (FTC)
Description: Capsule containing 200 mg FTC, taken once daily, for 96 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir Disoproxil Fumarate (TDF)
Description: Tablet containing 300 mg TDF, taken once daily, for 96 weeks

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Efavirenz (EFV)
Description: Tablet containing 600 mg EFV, taken once daily, for 96 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)
Description: Tablet containing 600 mg EFV, taken once daily, for 96 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FTC/TDF
Description: Fixed-dose combination tablet containing FTC 200 mg/TDF 300 mg, once daily, from Week 96 to 144

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FTC/TDF/EFV
Description: Fixed-dose combination tablet containing FTC 200 mg/TDF 300 mg/EFV 600 mg, taken once daily, from Week 144 to 240

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamivudine/zidovudine
Description: Fixed-dose combination tablet containing lamivudine 150 mg/zidovudine 300 mg, taken twice daily, for 240 weeks
Study: NCT01986673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 5% Sildenafil Cream (SST-6006)
Description: 5 % Sildenafil Cream

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral Sildenafil 50 mg
Description: Oral Sildenafil 50 mg
Study: NCT00559611

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endobronchial Ultrasound
Description: A small flexible scope is passed down the windpipe. Samples of lymph gland tissue will be collected through a tiny needle that is passed through the scope.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mediastinoscopy
Description: Performed if a tumor is not found on the opposite side of your chest from another tumor by the EBUS.
Study: NCT02346045

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Renal sympathetic denervation
Description: In the experimental arm, Intervention is renal sympathetic denervation using Symplicity® system (Medtronic Ardian Inc, Mountain View, CA, USA) and antihypertensive medications previously prescribed~1. After femoral puncture guiding catheter is engaged in renal artery~2. Symplicity radiofrequency ablation catheter is inserted into renal artery and by circular sequence, from distal to proximal portion, ablation energy is applied to the wall of renal artery~3. 4-5 ablations are applied in each renal artery.~In the sham comparator, intervention is renal angiogram and continue antihypertensive medications previuosly decribed
Study: NCT03217708

Intervention type: DEVICE
Intervention: Jawbone UP4
Description: Wrist worn wearable technology will be utilized to study HR, temperature, sleep, activity changes before and after surgery.
Study: NCT00724568

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Patients will be treated with Revlimid on days 1-14 in 3-week cycles for 4-8 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: Patients will be treated with Velcade at 1.3 mg/m2 on days 1, 4, 8, and 11

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Patients will be treated with Dexamethasone at 20 mg orally on days of Velcade and the day after for all dose levels.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxil
Description: Patients will be treated with Doxil on day 4.
Study: NCT04384549

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCG GROUP
Description: One intradermal injection of 0.1 ml of BCG vaccine (AJ Vaccine).Each 0.1 ml vaccine contains between 2 to 8 x 105 colony forming units.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO GROUP
Description: One intradermal injection of 0.1ml NaCl
Study: NCT00958243

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSL's 2009 H1N1 Influenza Vaccine (CSL425)
Description: 0.5 mL intramuscular injection on Day 0 and Day 21

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CSL's 2009 H1N1 Influenza Vaccine (CSL425)
Description: 0.25 mL intramuscular injection on Day 0 and Day 21

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT01103505

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: ForeseeHome AMD Monitoring Device
Description: Earlier detection of progression from intermediate dry age-related macular degeneration to CNV between routine eye exams through home diagnostic testing with the ForeseeHome AMD Monitoring device
Study: NCT01171495

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Theragran-M; Ensure Plus
Description: Theragran-M: One tablet daily for 6-months. Ensure Plus: One 8 fl.oz. bottle daily for 6-months. Nutritional counselling: at baseline, and at monthly follow-up visits.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Theragran-M
Description: Theragran-M: One tablet daily for 6-months. Nutritional counselling: at baseline and at monthly follow-up visits.
Study: NCT03475784

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Restrictive fluid therapy
Description: This group will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2 mL/Kg/hour.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Liberal fluid therapy
Description: This group will receive crystalloid preload of 5 mL/Kg, then will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 6 mL/Kg/hour.
Study: NCT01473966

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: coffee
Description: patients will receive a cup of coffee at room temperature orally twice daily

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: coffee rectally
Description: patients receive an enema of two cups of coffee at room temperature once daily
Study: NCT00966953

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluoride
Description: Brush twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triclosan/Fluoride toothpaste
Description: Brush twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluoride
Description: Brush twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluoride
Description: Brush twice daily

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: antibacterial plant extract
Description: Brush twice daily
Study: NCT03151239

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NMN supplement
Description: Intervention will last at least 8 weeks in the form of two capsules (250 mg total).

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Intervention will last at least 8 weeks in the form of two capsules.
Study: NCT03931863

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron 4mg
Description: Intravenous administration of ondansetron 4mg diluted in 100ml of normal saline 0.9 percent within 10 minutes prior to spinal anesthesia.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ondansetron 8mg
Description: Intravenous administration of ondansetron 8mg diluted in 100ml of normal saline 0.9 percent within 10 minutes prior to spinal anesthesia.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 100ml normal saline 0.9 percent
Description: Intravenous administration of 100ml of normal saline 0.9 percent within 10 minutes prior to spinal anesthesia.
Study: NCT00859664

Intervention type: OTHER
Intervention: Genotyping of Cytochrome P450
Description: Genotyping of Cytochrome P450
Study: NCT01153048

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensification of education
Description: The main objective is to assess impact of the establishment of involved patients (peer educators) network in Mali. Peer educators and persons targeted by the project will be recruited through Post-Test Club on diabetes (PTC). PTC will be a social support club that provides on going prevention counseling, education and support services to people who have diabetes. PTC represents an important link between patients, educators and general medical services. PTC will be defined as clubs, which are facilitated by well-trained peer educators, and will have 3 objectives: to provide social and emotional support to diabetic patients, to provide assistance in daily management and living with diabetes and to provide linkage to clinical care. To lead the sessions, in clubs, we will use a very innovative methodology for peer education: the learning nests method. To evaluate, we propose a classical randomized controlled experimental (RCT) design, with randomization at the person-level.
Study: NCT01000896

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0530
Description: film coated tablet, PO, daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: intravenous, 3 weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Description: intravenous, 3 weeks
Study: NCT01484405

Intervention type: PROCEDURE
Group type: OTHER
Intervention: posterior approach
Description: Surgical approach for Total Hip Arthroplasty

Intervention type: PROCEDURE
Group type: OTHER
Intervention: anterolateral approach
Description: anterolateral surgical approach